Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keystone

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Arthritis and Rheumatism|September 30, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritisT Karonitsch, D Aletaha, M Boers, et al.
Arthritis and Rheumatism|September 30, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Pageof 4